Ryan E. Morgan

738 total citations
12 papers, 576 citations indexed

About

Ryan E. Morgan is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ryan E. Morgan has authored 12 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ryan E. Morgan's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Ryan E. Morgan is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Ryan E. Morgan collaborates with scholars based in United States, United Kingdom and Austria. Ryan E. Morgan's co-authors include Hisham K. Hamadeh, Cynthia A. Afshari, Paul H. Lee, Yuan Chen, Robert T. Dunn, Michael Trauner, Charles W. Qualls, Michael Eschenberg, Ruth Lightfoot-Dunn and David Monteith and has published in prestigious journals such as PLoS ONE, Toxicology and Applied Pharmacology and Toxicological Sciences.

In The Last Decade

Ryan E. Morgan

11 papers receiving 556 citations

Peers

Countries citing papers authored by Ryan E. Morgan

Since Specialization

Citations

This map shows the geographic impact of Ryan E. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan E. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan E. Morgan more than expected).

Fields of papers citing papers by Ryan E. Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan E. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan E. Morgan. The network helps show where Ryan E. Morgan may publish in the future.

Co-authorship network of co-authors of Ryan E. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan E. Morgan. A scholar is included among the top collaborators of Ryan E. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan E. Morgan. Ryan E. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Biogelx-IKVAV Is An Innovative Human Platelet Lysate-Adipose-Derived Stem Cells Delivery Strategy to Improve Peripheral Nerve Repair 2024 ·Tissue Engineering Part A ·(unknown), Alison Clayton, Ryan E. Morgan, Wassim Raffoul, Andrew Hart, Mathis O. Riehle, Pietro G. di Summa	4
2	Considerations and derivations of permitted daily exposure limits for impurities from intravitreal pharmaceutical products 2024 ·Regulatory Toxicology and Pharmacology ·(unknown), David G. Dolan, (unknown), Ryan E. Morgan, Michael R. Garry, Joyce S. Tsuji	0
3	Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition 2018 ·Drug Metabolism and Disposition ·(unknown), Ryan E. Morgan, Yuan Chen, Laurie P. Volak, Robert T. Dunn, Kenneth W. Dunn	14
4	A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function 2018 ·PLoS ONE ·(unknown), Stephen C. Lenhard, (unknown), Mikael Forsgren, Serguei Liachenko, Edvin Johansson, Mark Pilling, Richard A. Peterson, Xi Yang, Dominic P. Williams, (unknown), Ryan E. Morgan, Kim L. R. Brouwer, Beat M. Jucker, Paul Hockings	10
5	Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition 2017 ·Toxicology and Applied Pharmacology ·Steven Cepa, David M. Potter, (unknown), Leah Schutt, Jacqueline M. Tarrant, Jodie Pang, Xiaolin Zhang, (unknown), Laurent Salphati, Yingqing Ran, (unknown), Ryan E. Morgan, Jonathan Maher	20
6	A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development 2013 ·Toxicological Sciences ·Ryan E. Morgan, (unknown), Yuan Chen, (unknown), (unknown), Robert T. Dunn, Cynthia A. Afshari, Hisham K. Hamadeh	188
7	Membrane Vesicle ABC Transporter Assays for Drug Safety Assessment 2012 ·Current Protocols in Toxicology ·(unknown), Ryan E. Morgan, (unknown), Yuan Chen, Paul H. Lee, Hisham K. Hamadeh	19
8	Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development 2010 ·Toxicological Sciences ·Ryan E. Morgan, Michael Trauner, (unknown), Paul H. Lee, (unknown), Michael Eschenberg, Cynthia A. Afshari, Charles W. Qualls, Ruth Lightfoot-Dunn, Hisham K. Hamadeh	255
9	In vitroassays and biomarkers for drug-induced phospholipidosis 2006 ·Expert Opinion on Drug Metabolism & Toxicology ·David Monteith, Ryan E. Morgan, (unknown)	29
10	A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red 2005 ·Journal of Applied Toxicology ·(unknown), Craig Zwickl, Ryan E. Morgan, David Monteith, Craig E. Thomas, (unknown), Brian R. Berridge	19
11	Screening and synthesis: high throughput technologies applied to parasitology 2004 ·Parasitology ·Ryan E. Morgan, Nicholas J. Westwood	4
12	Susceptibility of pine plantations to attack by the pine shoot beetle (Tomicus piniperda) in southern Ontario 2004 ·Canadian Journal of Forest Research ·Ryan E. Morgan, Peter de Groot, Sandy M. Smith	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact